BioIVT - The True Cost of Poor-Quality Specimens

BioIVT.com

THE TRUE COST OF POOR-QUALITY SPECIMENS

Poor-quality specimens result in high failure rates, costing you time and money.

According to a US survey of National Cancer Institute (NCI) funded cancer researchers, lack of quality biospecimens resulted in 60% of researchers questioning their findings and 81% limiting the scope of their work.¹

What is poor specimen quality costing you?

Avoid These Hidden Costs by Using a High-Quality Provider

ASTERAND® Human Tissue samples have had a <1% reported issue rate for over 20 years and 1,000,000 processed samples.

The ASTERAND® portfolio is well established for its unparalleled quality. We ensure reliable, reproducible results by requiring consistent collection methods and stringent quality control processes.

¹Assessing the need for a standardized cancer Human Biobank (caHUB): findings from a national survey with cancer researchers. Massett HA1, Atkinson NL, Weber D, Myles R, Ryan C, Grady M, Compton C.; ²Simoens et al R&D Costs of New Medicines: A Landscape Analysis Front. Med., 26 October 2021

View Biospecimen Options

Discuss Your Research Needs with a BioIVT Specialist

Partner with Us for a Custom Solution

Click the button below to schedule a meeting with one of our
Business Development Managers.

BioIVT, formerly BioreclamationIVT, is a leading global provider of high-quality biological specimens and value-added services. By combining our technical expertise, exceptional customer service, and unparalleled access to biological specimens, BioIVT serves the research community as a trusted partner in ELEVATING SCIENCE®.

Recent Blogs

What Are Chimeric Antigen Receptor T Cell Therapies?

July 14, 2022

What Are Controls and Why Do We Need Them?

May 3, 2022